WebApr 10, 2024 · The company has a market cap of $103.43 billion, a PE ratio of 22.84, a price-to-earnings-growth ratio of 0.99 and a beta of 0.38. 3 High Dividend Stocks to Buy and Hold; Gilead Sciences (NASDAQ:GILD - Get Rating) last announced its earnings results on Thursday, February 2nd. The biopharmaceutical company reported $1.67 earnings per … Web1 day ago · Below is Validea's guru fundamental report for GILEAD SCIENCES, INC. (GILD). Of the 22 guru strategies we follow, GILD rates highest using our Multi-Factor …
GILD (Gilead Sciences) Market Cap - gurufocus.com
WebOct 31, 2024 · Institutional investors are Gilead Sciences, Inc.'s (NASDAQ:GILD) biggest bettors and were rewarded after last week's US$14b market cap gain Read full article Simply Wall St WebApr 13, 2024 · Gilead Sciences, Inc. (NASDAQ:GILD) announced today that its first quarter 2024 financial results will be released on Thursday, April 27, 2024 after the market … primergy cx2550/cx2570 m1
Gilead Sciences (GILD) Market Cap (2012-2024) History - Netcials
WebGilead Sciences Market Cap Score. Market Cap Score Chart. View Market Cap Score for GILD. Upgrade now. Sep '18. Jan '19. May '19 . 285.00. 270.00. 255.00. 240.00. … WebApr 11, 2024 · GILD’s market cap is 103.70 Bil. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often … WebApr 6, 2024 · Amgen (NASDAQ:AMGN) and Gilead Sciences (NASDAQ:GILD) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, community ranking, valuation, earnings, dividends and media … primergy f250